| |
MT group (N = 913)
|
PCI group (N = 1305)
|
CABG group (N = 899)
|
|---|
|
HR (95% CI)
|
P value
|
HR (95% CI)
|
P value
|
HR (95% CI)
|
P value
|
|---|
|
Death
|
|
Crude Model
|
1.00 (ref)
|
–
|
0.33 (0.27, 0.40)
|
< 0.0001
|
0.34 (0.27, 0.42)
|
< 0.0001
|
|
Multivariate adjusted Model
|
1.00 (ref)
|
–
|
0.40 (0.32, 0.51)
|
< 0.0001
|
0.33 (0.26, 0.44)
|
< 0.0001
|
|
Crude Model
|
3.03 (2.51, 3.66)
|
< 0.0001
|
1.00 (ref)
|
–
|
1.03 (0.81, 1.30)
|
0.8396
|
|
Multivariate adjusted Model
|
2.50 (1.98, 3.16)
|
< 0.0001
|
1.00 (ref)
|
–
|
0.83 (0.62, 1.12)
|
0.2215
|
|
MACCE
|
|
Crude Model
|
1.00 (ref)
| |
0.66 (0.58, 0.75)
|
< 0.0001
|
0.48 (0.41, 0.57)
|
< 0.0001
|
|
Multivariate adjusted Model
|
1.00 (ref)
| |
0.71 (0.60, 0.84)
|
< 0.0001
|
0.48 (0.39, 0.57)
|
< 0.0001
|
|
Crude Model
|
1.52 (1.33, 1.73)
|
< 0.0001
|
1.00 (ref)
|
–
|
0.73 (0.62, 0.86)
|
0.0001
|
|
Multivariate adjusted Model
|
1.41 (1.20, 1.66)
|
< 0.0001
|
1.00 (ref)
|
–
|
0.67 (0.55, 0.81)
|
< 0.0001
|
- MACCE major adverse cardiac and cerebrovascular events, HR hazard ratios, MT medical treatment, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting
